GeneFerm Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	654.88	521.16	793.77	633.96	522.33	368.3
Revenue Growth (YoY)	19.26%	-34.34%	25.21%	21.37%	41.82%	12.21%
Cost of Revenue	491.65	424.42	507.42	411.8	329.68	246.32
Gross Profit	163.23	96.75	286.35	222.16	192.65	121.98
Selling, General & Admin	108.69	102.93	104.88	96.71	88.82	81.53
Research & Development	32.96	29.31	28.33	24.18	23.56	22.41
Operating Expenses	142.08	131.15	132.79	120.17	113.82	104.86
Operating Income	21.15	-34.41	153.57	101.99	78.84	17.12
Interest Expense	-5.89	-4.44	-4.17	-3.82	-7.32	-9.83
Interest & Investment Income	1.54	1.54	0.92	0.33	0.21	0.18
Currency Exchange Gain (Loss)	-7.88	4.8	0.84	9.66	-2.67	-3.08
Other Non Operating Income (Expenses)	5.45	5.03	2.27	2.6	1.51	1.94
EBT Excluding Unusual Items	14.37	-27.49	153.42	110.76	70.57	6.33
Gain (Loss) on Sale of Investments	-	-	-	-0.43	-	-
Gain (Loss) on Sale of Assets	-0.26	0.02	0.01	-0.11	0.04	0.44
Other Unusual Items	-	-	-	-	-0.21	-
Pretax Income	14.11	-27.47	153.43	110.21	70.4	6.77
Income Tax Expense	-1.96	-4.94	28.81	16.76	12.98	2.24
Net Income	16.07	-22.53	124.62	93.45	57.41	4.53
Net Income to Common	16.07	-22.53	124.62	93.45	57.41	4.53
Net Income Growth	-	-	33.35%	62.78%	1167.67%	-
Shares Outstanding (Basic)	41	41	41	41	40	28
Shares Outstanding (Diluted)	41	41	42	43	46	28
Shares Change (YoY)	0.03%	-0.36%	-2.26%	-8.00%	65.83%	0.19%
EPS (Basic)	0.39	-0.54	3.01	2.26	1.45	0.16
EPS (Diluted)	0.39	-0.54	2.99	2.20	1.32	0.16
EPS Growth	-	-	35.63%	66.87%	725.71%	-
Free Cash Flow	85.39	-14.31	120.37	-155.74	-32.65	-25.9
Free Cash Flow Per Share	2.06	-0.34	2.89	-3.66	-0.70	-0.93
Dividend Per Share	-	-	2.000	1.500	1.000	0.083
Dividend Growth	-	-	33.33%	50.00%	1103.93%	-
Gross Margin	24.92%	18.56%	36.08%	35.04%	36.88%	33.12%
Operating Margin	3.23%	-6.60%	19.35%	16.09%	15.09%	4.65%
Profit Margin	2.45%	-4.32%	15.70%	14.74%	10.99%	1.23%
Free Cash Flow Margin	13.04%	-2.74%	15.17%	-24.57%	-6.25%	-7.03%
EBITDA	89.79	37.89	219.41	145.16	117.76	51.63
EBITDA Margin	13.71%	7.27%	27.64%	22.90%	22.55%	14.02%
D&A For EBITDA	68.64	72.3	65.84	43.16	38.92	34.51
EBIT	21.15	-34.41	153.57	101.99	78.84	17.12
EBIT Margin	3.23%	-6.60%	19.35%	16.09%	15.09%	4.65%
Effective Tax Rate	-	-	18.78%	15.21%	18.44%	33.09%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.